#ID(s) interactor A	ID(s) interactor B	Alt. ID(s) interactor A	Alt. ID(s) interactor B	Alias(es) interactor A	Alias(es) interactor B	Interaction detection method(s)	Publication 1st author(s)	Publication Identifier(s)	Taxid interactor A	Taxid interactor B	Interaction type(s)	Source database(s)	Interaction identifier(s)	Confidence value(s)	Expansion method(s)	Biological role(s) interactor A	Biological role(s) interactor B	Experimental role(s) interactor A	Experimental role(s) interactor B	Type(s) interactor A	Type(s) interactor B	Xref(s) interactor A	Xref(s) interactor B	Interaction Xref(s)	Annotation(s) interactor A	Annotation(s) interactor B	Interaction annotation(s)	Host organism(s)	Interaction parameter(s)	Creation date	Update date	Checksum(s) interactor A	Checksum(s) interactor B	Interaction Checksum(s)	Negative	Feature(s) interactor A	Feature(s) interactor B	Stoichiometry(s) interactor A	Stoichiometry(s) interactor B	Identification method participant A	Identification method participant B
uniprotkb:Q2EEY0	uniprotkb:Q2EEY0	intact:EBI-16145055|ensembl:ENSECAP00000011919	intact:EBI-16145055|ensembl:ENSECAP00000011919	psi-mi:tlr9_horse(display_long)|uniprotkb:TLR9(gene name)|psi-mi:TLR9(display_short)	psi-mi:tlr9_horse(display_long)|uniprotkb:TLR9(gene name)|psi-mi:TLR9(display_short)	psi-mi:"MI:0028"(cosedimentation in solution)	Ohto et al. (2015)	pubmed:25686612|doi:10.1038/nature14138|imex:IM-24409	taxid:9796(horse)|taxid:9796("Equus caballus (Horse)")	taxid:9796(horse)|taxid:9796("Equus caballus (Horse)")	psi-mi:"MI:0407"(direct interaction)	psi-mi:"MI:0465"(DIP)	intact:EBI-16145122|imex:IM-24409-1|dip:DIP-199056E	-	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	ensembl:ENSECAG00000014294(gene)|ensembl:ENSECAT00000014884(transcript)|go:"GO:0001932"(regulation of protein phosphorylation)|go:"GO:0002218"(activation of innate immune response)|go:"GO:0002224"(toll-like receptor signaling pathway)|go:"GO:0002237"(response to molecule of bacterial origin)|go:"GO:0002639"(positive regulation of immunoglobulin production)|go:"GO:0002730"(regulation of dendritic cell cytokine production)|go:"GO:0002755"(MyD88-dependent toll-like receptor signaling pathway)|go:"GO:0004888"(transmembrane signaling receptor activity)|go:"GO:0005634"(nucleus)|go:"GO:0005737"(cytoplasm)|go:"GO:0005764"(lysosome)|go:"GO:0005789"(endoplasmic reticulum membrane)|go:"GO:0005886"(plasma membrane)|go:"GO:0006954"(inflammatory response)|go:"GO:0006955"(immune response)|go:"GO:0007249"(I-kappaB kinase/NF-kappaB signaling)|go:"GO:0016021"(integral component of membrane)|go:"GO:0030277"(maintenance of gastrointestinal epithelium)|go:"GO:0030890"(positive regulation of B cell proliferation)|go:"GO:0032009"(early phagosome)|go:"GO:0032715"(negative regulation of interleukin-6 production)|go:"GO:0032727"(positive regulation of interferon-alpha production)|go:"GO:0032728"(positive regulation of interferon-beta production)|go:"GO:0032729"(positive regulation of interferon-gamma production)|go:"GO:0032733"(positive regulation of interleukin-10 production)|go:"GO:0032735"(positive regulation of interleukin-12 production)|go:"GO:0032741"(positive regulation of interleukin-18 production)|go:"GO:0032755"(positive regulation of interleukin-6 production)|go:"GO:0032760"(positive regulation of tumor necrosis factor production)|go:"GO:0034162"(toll-like receptor 9 signaling pathway)|go:"GO:0034165"(positive regulation of toll-like receptor 9 signaling pathway)|go:"GO:0035197"(siRNA binding)|go:"GO:0036019"(endolysosome)|go:"GO:0038187"(pattern recognition receptor activity)|go:"GO:0042802"(identical protein binding)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0043410"(positive regulation of MAPK cascade)|go:"GO:0045087"(innate immune response)|go:"GO:0045322"(unmethylated CpG binding)|go:"GO:0045335"(phagocytic vesicle)|go:"GO:0045577"(regulation of B cell differentiation)|go:"GO:0045944"(positive regulation of transcription by RNA polymerase II)|go:"GO:0050729"(positive regulation of inflammatory response)|go:"GO:0050871"(positive regulation of B cell activation)|go:"GO:0051092"(positive regulation of NF-kappaB transcription factor activity)|go:"GO:0051607"(defense response to virus)|go:"GO:0051770"(positive regulation of nitric-oxide synthase biosynthetic process)|go:"GO:0070373"(negative regulation of ERK1 and ERK2 cascade)|go:"GO:1902350"(cellular response to chloroquine)|interpro:IPR000157(Toll-Interleukin receptor)|interpro:IPR001611(Leucine-rich repeat)|interpro:IPR003591(Leucine-rich repeat, typical subtype)|interpro:IPR027181|interpro:IPR035897|interpro:IPR041283|rcsb pdb:3WPB|rcsb pdb:3WPC|rcsb pdb:3WPD|rcsb pdb:5Y3J|rcsb pdb:5Y3K|rcsb pdb:5Y3L|refseq:NP_001075259.1|dip:DIP-61513N	ensembl:ENSECAG00000014294(gene)|ensembl:ENSECAT00000014884(transcript)|go:"GO:0001932"(regulation of protein phosphorylation)|go:"GO:0002218"(activation of innate immune response)|go:"GO:0002224"(toll-like receptor signaling pathway)|go:"GO:0002237"(response to molecule of bacterial origin)|go:"GO:0002639"(positive regulation of immunoglobulin production)|go:"GO:0002730"(regulation of dendritic cell cytokine production)|go:"GO:0002755"(MyD88-dependent toll-like receptor signaling pathway)|go:"GO:0004888"(transmembrane signaling receptor activity)|go:"GO:0005634"(nucleus)|go:"GO:0005737"(cytoplasm)|go:"GO:0005764"(lysosome)|go:"GO:0005789"(endoplasmic reticulum membrane)|go:"GO:0005886"(plasma membrane)|go:"GO:0006954"(inflammatory response)|go:"GO:0006955"(immune response)|go:"GO:0007249"(I-kappaB kinase/NF-kappaB signaling)|go:"GO:0016021"(integral component of membrane)|go:"GO:0030277"(maintenance of gastrointestinal epithelium)|go:"GO:0030890"(positive regulation of B cell proliferation)|go:"GO:0032009"(early phagosome)|go:"GO:0032715"(negative regulation of interleukin-6 production)|go:"GO:0032727"(positive regulation of interferon-alpha production)|go:"GO:0032728"(positive regulation of interferon-beta production)|go:"GO:0032729"(positive regulation of interferon-gamma production)|go:"GO:0032733"(positive regulation of interleukin-10 production)|go:"GO:0032735"(positive regulation of interleukin-12 production)|go:"GO:0032741"(positive regulation of interleukin-18 production)|go:"GO:0032755"(positive regulation of interleukin-6 production)|go:"GO:0032760"(positive regulation of tumor necrosis factor production)|go:"GO:0034162"(toll-like receptor 9 signaling pathway)|go:"GO:0034165"(positive regulation of toll-like receptor 9 signaling pathway)|go:"GO:0035197"(siRNA binding)|go:"GO:0036019"(endolysosome)|go:"GO:0038187"(pattern recognition receptor activity)|go:"GO:0042802"(identical protein binding)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0043410"(positive regulation of MAPK cascade)|go:"GO:0045087"(innate immune response)|go:"GO:0045322"(unmethylated CpG binding)|go:"GO:0045335"(phagocytic vesicle)|go:"GO:0045577"(regulation of B cell differentiation)|go:"GO:0045944"(positive regulation of transcription by RNA polymerase II)|go:"GO:0050729"(positive regulation of inflammatory response)|go:"GO:0050871"(positive regulation of B cell activation)|go:"GO:0051092"(positive regulation of NF-kappaB transcription factor activity)|go:"GO:0051607"(defense response to virus)|go:"GO:0051770"(positive regulation of nitric-oxide synthase biosynthetic process)|go:"GO:0070373"(negative regulation of ERK1 and ERK2 cascade)|go:"GO:1902350"(cellular response to chloroquine)|interpro:IPR000157(Toll-Interleukin receptor)|interpro:IPR001611(Leucine-rich repeat)|interpro:IPR003591(Leucine-rich repeat, typical subtype)|interpro:IPR027181|interpro:IPR035897|interpro:IPR041283|rcsb pdb:3WPB|rcsb pdb:3WPC|rcsb pdb:3WPD|rcsb pdb:5Y3J|rcsb pdb:5Y3K|rcsb pdb:5Y3L|refseq:NP_001075259.1|dip:DIP-61513N	psi-mi:"MI:0465"(dip)	-	-	full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2017/08/08	2017/08/10	rogid:1eobKWcV9haqWXeGkTTz8nYLWi09796	rogid:1eobKWcV9haqWXeGkTTz8nYLWi09796	rigid:wz4R2H/tpPJLb01YlFzZg0mnrNU	false	sufficient binding region:26-817	sufficient binding region:26-817	-	0	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:Q2EEY0	uniprotkb:Q2EEY0	intact:EBI-16145055|ensembl:ENSECAP00000011919	intact:EBI-16145055|ensembl:ENSECAP00000011919	psi-mi:tlr9_horse(display_long)|uniprotkb:TLR9(gene name)|psi-mi:TLR9(display_short)	psi-mi:tlr9_horse(display_long)|uniprotkb:TLR9(gene name)|psi-mi:TLR9(display_short)	psi-mi:"MI:0114"(x-ray crystallography)	Ohto et al. (2015)	pubmed:25686612|doi:10.1038/nature14138|imex:IM-24409	taxid:9796(horse)|taxid:9796("Equus caballus (Horse)")	taxid:9796(horse)|taxid:9796("Equus caballus (Horse)")	psi-mi:"MI:0407"(direct interaction)	psi-mi:"MI:0465"(DIP)	intact:EBI-16145141|imex:IM-24409-2|dip:DIP-199056E	-	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	ensembl:ENSECAG00000014294(gene)|ensembl:ENSECAT00000014884(transcript)|go:"GO:0001932"(regulation of protein phosphorylation)|go:"GO:0002218"(activation of innate immune response)|go:"GO:0002224"(toll-like receptor signaling pathway)|go:"GO:0002237"(response to molecule of bacterial origin)|go:"GO:0002639"(positive regulation of immunoglobulin production)|go:"GO:0002730"(regulation of dendritic cell cytokine production)|go:"GO:0002755"(MyD88-dependent toll-like receptor signaling pathway)|go:"GO:0004888"(transmembrane signaling receptor activity)|go:"GO:0005634"(nucleus)|go:"GO:0005737"(cytoplasm)|go:"GO:0005764"(lysosome)|go:"GO:0005789"(endoplasmic reticulum membrane)|go:"GO:0005886"(plasma membrane)|go:"GO:0006954"(inflammatory response)|go:"GO:0006955"(immune response)|go:"GO:0007249"(I-kappaB kinase/NF-kappaB signaling)|go:"GO:0016021"(integral component of membrane)|go:"GO:0030277"(maintenance of gastrointestinal epithelium)|go:"GO:0030890"(positive regulation of B cell proliferation)|go:"GO:0032009"(early phagosome)|go:"GO:0032715"(negative regulation of interleukin-6 production)|go:"GO:0032727"(positive regulation of interferon-alpha production)|go:"GO:0032728"(positive regulation of interferon-beta production)|go:"GO:0032729"(positive regulation of interferon-gamma production)|go:"GO:0032733"(positive regulation of interleukin-10 production)|go:"GO:0032735"(positive regulation of interleukin-12 production)|go:"GO:0032741"(positive regulation of interleukin-18 production)|go:"GO:0032755"(positive regulation of interleukin-6 production)|go:"GO:0032760"(positive regulation of tumor necrosis factor production)|go:"GO:0034162"(toll-like receptor 9 signaling pathway)|go:"GO:0034165"(positive regulation of toll-like receptor 9 signaling pathway)|go:"GO:0035197"(siRNA binding)|go:"GO:0036019"(endolysosome)|go:"GO:0038187"(pattern recognition receptor activity)|go:"GO:0042802"(identical protein binding)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0043410"(positive regulation of MAPK cascade)|go:"GO:0045087"(innate immune response)|go:"GO:0045322"(unmethylated CpG binding)|go:"GO:0045335"(phagocytic vesicle)|go:"GO:0045577"(regulation of B cell differentiation)|go:"GO:0045944"(positive regulation of transcription by RNA polymerase II)|go:"GO:0050729"(positive regulation of inflammatory response)|go:"GO:0050871"(positive regulation of B cell activation)|go:"GO:0051092"(positive regulation of NF-kappaB transcription factor activity)|go:"GO:0051607"(defense response to virus)|go:"GO:0051770"(positive regulation of nitric-oxide synthase biosynthetic process)|go:"GO:0070373"(negative regulation of ERK1 and ERK2 cascade)|go:"GO:1902350"(cellular response to chloroquine)|interpro:IPR000157(Toll-Interleukin receptor)|interpro:IPR001611(Leucine-rich repeat)|interpro:IPR003591(Leucine-rich repeat, typical subtype)|interpro:IPR027181|interpro:IPR035897|interpro:IPR041283|rcsb pdb:3WPB|rcsb pdb:3WPC|rcsb pdb:3WPD|rcsb pdb:5Y3J|rcsb pdb:5Y3K|rcsb pdb:5Y3L|refseq:NP_001075259.1|dip:DIP-61513N	ensembl:ENSECAG00000014294(gene)|ensembl:ENSECAT00000014884(transcript)|go:"GO:0001932"(regulation of protein phosphorylation)|go:"GO:0002218"(activation of innate immune response)|go:"GO:0002224"(toll-like receptor signaling pathway)|go:"GO:0002237"(response to molecule of bacterial origin)|go:"GO:0002639"(positive regulation of immunoglobulin production)|go:"GO:0002730"(regulation of dendritic cell cytokine production)|go:"GO:0002755"(MyD88-dependent toll-like receptor signaling pathway)|go:"GO:0004888"(transmembrane signaling receptor activity)|go:"GO:0005634"(nucleus)|go:"GO:0005737"(cytoplasm)|go:"GO:0005764"(lysosome)|go:"GO:0005789"(endoplasmic reticulum membrane)|go:"GO:0005886"(plasma membrane)|go:"GO:0006954"(inflammatory response)|go:"GO:0006955"(immune response)|go:"GO:0007249"(I-kappaB kinase/NF-kappaB signaling)|go:"GO:0016021"(integral component of membrane)|go:"GO:0030277"(maintenance of gastrointestinal epithelium)|go:"GO:0030890"(positive regulation of B cell proliferation)|go:"GO:0032009"(early phagosome)|go:"GO:0032715"(negative regulation of interleukin-6 production)|go:"GO:0032727"(positive regulation of interferon-alpha production)|go:"GO:0032728"(positive regulation of interferon-beta production)|go:"GO:0032729"(positive regulation of interferon-gamma production)|go:"GO:0032733"(positive regulation of interleukin-10 production)|go:"GO:0032735"(positive regulation of interleukin-12 production)|go:"GO:0032741"(positive regulation of interleukin-18 production)|go:"GO:0032755"(positive regulation of interleukin-6 production)|go:"GO:0032760"(positive regulation of tumor necrosis factor production)|go:"GO:0034162"(toll-like receptor 9 signaling pathway)|go:"GO:0034165"(positive regulation of toll-like receptor 9 signaling pathway)|go:"GO:0035197"(siRNA binding)|go:"GO:0036019"(endolysosome)|go:"GO:0038187"(pattern recognition receptor activity)|go:"GO:0042802"(identical protein binding)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0043410"(positive regulation of MAPK cascade)|go:"GO:0045087"(innate immune response)|go:"GO:0045322"(unmethylated CpG binding)|go:"GO:0045335"(phagocytic vesicle)|go:"GO:0045577"(regulation of B cell differentiation)|go:"GO:0045944"(positive regulation of transcription by RNA polymerase II)|go:"GO:0050729"(positive regulation of inflammatory response)|go:"GO:0050871"(positive regulation of B cell activation)|go:"GO:0051092"(positive regulation of NF-kappaB transcription factor activity)|go:"GO:0051607"(defense response to virus)|go:"GO:0051770"(positive regulation of nitric-oxide synthase biosynthetic process)|go:"GO:0070373"(negative regulation of ERK1 and ERK2 cascade)|go:"GO:1902350"(cellular response to chloroquine)|interpro:IPR000157(Toll-Interleukin receptor)|interpro:IPR001611(Leucine-rich repeat)|interpro:IPR003591(Leucine-rich repeat, typical subtype)|interpro:IPR027181|interpro:IPR035897|interpro:IPR041283|rcsb pdb:3WPB|rcsb pdb:3WPC|rcsb pdb:3WPD|rcsb pdb:5Y3J|rcsb pdb:5Y3K|rcsb pdb:5Y3L|refseq:NP_001075259.1|dip:DIP-61513N	psi-mi:"MI:0465"(dip)	-	-	full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2017/08/08	2017/08/10	rogid:1eobKWcV9haqWXeGkTTz8nYLWi09796	rogid:1eobKWcV9haqWXeGkTTz8nYLWi09796	rigid:wz4R2H/tpPJLb01YlFzZg0mnrNU	false	sufficient binding region:26-817	sufficient binding region:26-817	-	0	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:Q5I2M5	uniprotkb:Q5I2M5	intact:EBI-16145160	intact:EBI-16145160	psi-mi:tlr9_bovin(display_long)|uniprotkb:TLR9(gene name)|psi-mi:TLR9(display_short)	psi-mi:tlr9_bovin(display_long)|uniprotkb:TLR9(gene name)|psi-mi:TLR9(display_short)	psi-mi:"MI:0114"(x-ray crystallography)	Ohto et al. (2015)	pubmed:25686612|doi:10.1038/nature14138|imex:IM-24409	taxid:9913(bovin)|taxid:9913("Bos taurus (Bovine)")	taxid:9913(bovin)|taxid:9913("Bos taurus (Bovine)")	psi-mi:"MI:0407"(direct interaction)	psi-mi:"MI:0465"(DIP)	intact:EBI-16145203|imex:IM-24409-3|dip:DIP-199057E	-	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	go:"GO:0002218"(activation of innate immune response)|go:"GO:0002224"(toll-like receptor signaling pathway)|go:"GO:0002237"(response to molecule of bacterial origin)|go:"GO:0002639"(positive regulation of immunoglobulin production)|go:"GO:0002755"(MyD88-dependent toll-like receptor signaling pathway)|go:"GO:0004888"(transmembrane signaling receptor activity)|go:"GO:0005764"(lysosome)|go:"GO:0005768"(endosome)|go:"GO:0005783"(endoplasmic reticulum)|go:"GO:0005789"(endoplasmic reticulum membrane)|go:"GO:0005886"(plasma membrane)|go:"GO:0006954"(inflammatory response)|go:"GO:0006955"(immune response)|go:"GO:0007249"(I-kappaB kinase/NF-kappaB signaling)|go:"GO:0016021"(integral component of membrane)|go:"GO:0030890"(positive regulation of B cell proliferation)|go:"GO:0032009"(early phagosome)|go:"GO:0032727"(positive regulation of interferon-alpha production)|go:"GO:0032728"(positive regulation of interferon-beta production)|go:"GO:0032729"(positive regulation of interferon-gamma production)|go:"GO:0032755"(positive regulation of interleukin-6 production)|go:"GO:0034162"(toll-like receptor 9 signaling pathway)|go:"GO:0034165"(positive regulation of toll-like receptor 9 signaling pathway)|go:"GO:0035197"(siRNA binding)|go:"GO:0036019"(endolysosome)|go:"GO:0038187"(pattern recognition receptor activity)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0043410"(positive regulation of MAPK cascade)|go:"GO:0045087"(innate immune response)|go:"GO:0045322"(unmethylated CpG binding)|go:"GO:0045577"(regulation of B cell differentiation)|go:"GO:0050729"(positive regulation of inflammatory response)|go:"GO:0050871"(positive regulation of B cell activation)|go:"GO:0051092"(positive regulation of NF-kappaB transcription factor activity)|go:"GO:0051607"(defense response to virus)|interpro:IPR000157(Toll-Interleukin receptor)|interpro:IPR001611(Leucine-rich repeat)|interpro:IPR003591(Leucine-rich repeat, typical subtype)|interpro:IPR027181|interpro:IPR035897|interpro:IPR041283|rcsb pdb:3WPE|rcsb pdb:5Y3M|dip:DIP-61514N	go:"GO:0002218"(activation of innate immune response)|go:"GO:0002224"(toll-like receptor signaling pathway)|go:"GO:0002237"(response to molecule of bacterial origin)|go:"GO:0002639"(positive regulation of immunoglobulin production)|go:"GO:0002755"(MyD88-dependent toll-like receptor signaling pathway)|go:"GO:0004888"(transmembrane signaling receptor activity)|go:"GO:0005764"(lysosome)|go:"GO:0005768"(endosome)|go:"GO:0005783"(endoplasmic reticulum)|go:"GO:0005789"(endoplasmic reticulum membrane)|go:"GO:0005886"(plasma membrane)|go:"GO:0006954"(inflammatory response)|go:"GO:0006955"(immune response)|go:"GO:0007249"(I-kappaB kinase/NF-kappaB signaling)|go:"GO:0016021"(integral component of membrane)|go:"GO:0030890"(positive regulation of B cell proliferation)|go:"GO:0032009"(early phagosome)|go:"GO:0032727"(positive regulation of interferon-alpha production)|go:"GO:0032728"(positive regulation of interferon-beta production)|go:"GO:0032729"(positive regulation of interferon-gamma production)|go:"GO:0032755"(positive regulation of interleukin-6 production)|go:"GO:0034162"(toll-like receptor 9 signaling pathway)|go:"GO:0034165"(positive regulation of toll-like receptor 9 signaling pathway)|go:"GO:0035197"(siRNA binding)|go:"GO:0036019"(endolysosome)|go:"GO:0038187"(pattern recognition receptor activity)|go:"GO:0042803"(protein homodimerization activity)|go:"GO:0043410"(positive regulation of MAPK cascade)|go:"GO:0045087"(innate immune response)|go:"GO:0045322"(unmethylated CpG binding)|go:"GO:0045577"(regulation of B cell differentiation)|go:"GO:0050729"(positive regulation of inflammatory response)|go:"GO:0050871"(positive regulation of B cell activation)|go:"GO:0051092"(positive regulation of NF-kappaB transcription factor activity)|go:"GO:0051607"(defense response to virus)|interpro:IPR000157(Toll-Interleukin receptor)|interpro:IPR001611(Leucine-rich repeat)|interpro:IPR003591(Leucine-rich repeat, typical subtype)|interpro:IPR027181|interpro:IPR035897|interpro:IPR041283|rcsb pdb:3WPE|rcsb pdb:5Y3M|dip:DIP-61514N	psi-mi:"MI:0465"(dip)	-	-	full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2017/08/08	2017/08/10	rogid:Pi3Edxh4tdKELhxtnT+AT+sb6oI9913	rogid:Pi3Edxh4tdKELhxtnT+AT+sb6oI9913	rigid:Mr0uFv1nKpgYAvrCl+aeOyGDdFs	false	sufficient binding region:25-815	sufficient binding region:25-815	-	0	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)